Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients (EPOC_2_0)
Primary Purpose
Pulmonary Disease, Chronic Obstructive, Breathing Exercises, Exercise Tolerance
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Exercise training program with and without FB
Sponsored by
About this trial
This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive focused on measuring Pulmonary rehabilitation, Medical device, FeelBreathe, Exercise intervention, Equipment and Supplies
Eligibility Criteria
Inclusion Criteria:
- men with diagnosis of COPD according to guidelines criteria
- with moderate or severe airflow obstruction (GOLD 2 or 3)
- dyspnea grade 2 or greater by mMRC scale
- stable clinical condition for at least 2 months.
Exclusion Criteria:
- poor compliance
- treatment with oxygen therapy or non-invasive mechanical ventilation
- CO2 retention
- medical conditions that can produce or increase dyspnea on exercise in addition to COPD (cardiovascular, metabolic or other respiratory diseases)
- osteoarticular or neuromuscular diseases that may limit the correct performance of the 6MWT
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
No Intervention
Arm Label
FB group
ONB group
control group (CG)
Arm Description
Participants who performed an exercise training program for 8 weeks using a nasal restriction device for inspiratory muscle training, called Feelbreathe®
Participants who performed an exercise training program for 8 weeks with oronasal breathing without FB
Participants who received the standard medical recommendations for patients with COPD, but not participated in the exercise intervention program
Outcomes
Primary Outcome Measures
Oxygen uptake during incremental test to exhaustion on treadmill
mL/min
Ventilation during incremental test to exhaustion on treadmill
L/min
Secondary Outcome Measures
dyspnea scale
mMRC (Modified Medical Research Council) Dyspnea Scale. Values from 0 (better) to 4 (worse) about disability attributable to breathlessness
The COPD Assessment Test (CAT) is a questionnaire for people with Chronic Obstructive Pulmonary Disease (COPD)
The COPD Assessment Test (CAT) score measures the impact that COPD (Chronic Obstructive Pulmonary Disease) is having on the wellbeing and daily life of the patient. Score from 0 (better) to 40 (worse) about the impact of COPD symptoms on patients' overall health.
exercise capacity using the distance walked in the six minutes walking test (6MWT)
distance measured in meters
Full Information
NCT ID
NCT03936348
First Posted
April 28, 2019
Last Updated
May 29, 2019
Sponsor
University of Cadiz
Collaborators
Sociedad Española de Neumología y Cirugía Torácica, Hospital Universitario Puerta del Mar, Bahía Sur Andalusian Center for Sports Medicine
1. Study Identification
Unique Protocol Identification Number
NCT03936348
Brief Title
Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients
Acronym
EPOC_2_0
Official Title
Evaluation of a Respiratory Muscle Training Program Restricting Nasal Breathing With FeelBreathe® Device in COPD Patients
Study Type
Interventional
2. Study Status
Record Verification Date
May 2019
Overall Recruitment Status
Completed
Study Start Date
January 15, 2016 (Actual)
Primary Completion Date
July 25, 2017 (Actual)
Study Completion Date
December 18, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Cadiz
Collaborators
Sociedad Española de Neumología y Cirugía Torácica, Hospital Universitario Puerta del Mar, Bahía Sur Andalusian Center for Sports Medicine
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study evaluates the effects of a nasal restriction device for inspiratory muscle training (FeelBreathe) after 8 weeks of exercise intervention on exercise capacity, quality of life, dyspnea and inspitarotory muscle strength in patients with stable COPD. Participants were divided in three groups: 1) exercise intervention using the Feelbreathe® device (FB group), 2) exercise intervention with oronasal breathing without FB (ONB group) and 3) no participation in the exercise intervention as control group (CG).
Detailed Description
The Feelbreathe® device, tested in the investigator's study can be used in static and dynamic situations and is a nasal ventilatory flow restriction device made by a strip of hypoallergenic material (3M Spain, S.A. Medical Specialties / O.E.M.) that is placed and adhered under the nostrils impairing the free pass of air through the nose by producing resistance to flow. Depend on the size or/and porosity of the device, the inspiratory process is more or less difficult. It can be used while performing dynamic exercise or doing daily living activities. The Feelbreathe® device (FB) has been authorized by the Spanish Agency for Medicines and Health Products for application on COPD patients (Expedient 521/15/EC. AEMPS-Madrid-Spain-Patent Nº: P200902402).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive, Breathing Exercises, Exercise Tolerance
Keywords
Pulmonary rehabilitation, Medical device, FeelBreathe, Exercise intervention, Equipment and Supplies
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
Patients were randomized to 3 groups. The first one performed a supervised RP using the Feelbreathe® device (FB group), the second group developed the same RP with oronasal breathing without FB (ONB group) and the third was the control group (CG). The RP was conducted during 8 weeks, 3 days per week, and includes a combined training of endurance and strength exercises.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
16 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FB group
Arm Type
Experimental
Arm Description
Participants who performed an exercise training program for 8 weeks using a nasal restriction device for inspiratory muscle training, called Feelbreathe®
Arm Title
ONB group
Arm Type
Experimental
Arm Description
Participants who performed an exercise training program for 8 weeks with oronasal breathing without FB
Arm Title
control group (CG)
Arm Type
No Intervention
Arm Description
Participants who received the standard medical recommendations for patients with COPD, but not participated in the exercise intervention program
Intervention Type
Device
Intervention Name(s)
Exercise training program with and without FB
Other Intervention Name(s)
Pulmonary rehabilitation program
Intervention Description
Participants carried out a supervised RP for 8 weeks, 3 days per week. The training sessions lasted 60 minutes and included a warning up phase, the main phase and a recovery phase. After each session, Borg's perceived exertion was measured. The Rehabilitation Program (RP) included aerobic exercise on cycle ergometer and on treadmill (progressing since 10' to 30' and since 40 to 75% of the reserve heart rate (RHR) or 6-7 score based on Borg's perceived exertion), strengthening of lower and upper limb muscles groups, breathing exercises (pursed lip breathing, diaphragmatic and abdominal breathing and diaphragmatic mobility) and finally stretching exercises.
In the FB group, for restricted nasal breathing, at the beginning of the training program, the small size device was used (4 mm). The size of the device was progressively increasing according to the patient adaptation to the 5 or 6 mm device, depending on the score on Borg's perceived exertion scale.
Primary Outcome Measure Information:
Title
Oxygen uptake during incremental test to exhaustion on treadmill
Description
mL/min
Time Frame
8 WEEKS
Title
Ventilation during incremental test to exhaustion on treadmill
Description
L/min
Time Frame
8 WEEKS
Secondary Outcome Measure Information:
Title
dyspnea scale
Description
mMRC (Modified Medical Research Council) Dyspnea Scale. Values from 0 (better) to 4 (worse) about disability attributable to breathlessness
Time Frame
8 WEEKS
Title
The COPD Assessment Test (CAT) is a questionnaire for people with Chronic Obstructive Pulmonary Disease (COPD)
Description
The COPD Assessment Test (CAT) score measures the impact that COPD (Chronic Obstructive Pulmonary Disease) is having on the wellbeing and daily life of the patient. Score from 0 (better) to 40 (worse) about the impact of COPD symptoms on patients' overall health.
Time Frame
8 WEEKS
Title
exercise capacity using the distance walked in the six minutes walking test (6MWT)
Description
distance measured in meters
Time Frame
8 WEEKS
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
men with diagnosis of COPD according to guidelines criteria
with moderate or severe airflow obstruction (GOLD 2 or 3)
dyspnea grade 2 or greater by mMRC scale
stable clinical condition for at least 2 months.
Exclusion Criteria:
poor compliance
treatment with oxygen therapy or non-invasive mechanical ventilation
CO2 retention
medical conditions that can produce or increase dyspnea on exercise in addition to COPD (cardiovascular, metabolic or other respiratory diseases)
osteoarticular or neuromuscular diseases that may limit the correct performance of the 6MWT
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jose L González Montesinos, PhD
Organizational Affiliation
University of Cádiz
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Since there is personal and not transferable data
Citations:
Citation
González-Montesinos JL, Vaz Pardal C, Fernández Santos JR, Arnedillo Muñoz A CSJ y GE de los MR. Efectos del entrenamiento de la musculatura respiratoria sobre el rendimiento. Revisión bibliográfica. Rev Andal Med Deport. 2012;5(4):163-70.
Results Reference
background
Citation
González Montesinos JL, Costa Sepúlveda JL, Fernández Santos J, Gómez Espinosa de los Monteros R, Mora Vicente J, Castro Piñero J y, et al. Dispositivo de Restricción y Filtrado del Flujo Ventilatorio Nasal. P200902402, 2011. p. 1-4.
Results Reference
result
PubMed Identifier
27238811
Citation
Gonzalez-Montesinos JL, Ponce-Gonzalez JG, Vicente-Campos D, Lopez-Chicharro J, Fernandez-Santos Jdel R, Vaz-Pardal C, Costa-Sepulveda JL, Conde-Caveda J, Castro-Pinero J. Efectos de un dispositivo de restriccion ventilatoria nasal sobre la ventilacion pulmonar e intercambio gaseoso durante el ejercicio en personas sanas. Nutr Hosp. 2016 Mar 25;33(2):130. doi: 10.20960/nh.130.
Results Reference
result
PubMed Identifier
11069801
Citation
Scherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med. 2000 Nov;162(5):1709-14. doi: 10.1164/ajrccm.162.5.9912026.
Results Reference
result
PubMed Identifier
27822031
Citation
Wada JT, Borges-Santos E, Porras DC, Paisani DM, Cukier A, Lunardi AC, Carvalho CR. Effects of aerobic training combined with respiratory muscle stretching on the functional exercise capacity and thoracoabdominal kinematics in patients with COPD: a randomized and controlled trial. Int J Chron Obstruct Pulmon Dis. 2016 Oct 28;11:2691-2700. doi: 10.2147/COPD.S114548. eCollection 2016.
Results Reference
result
PubMed Identifier
27730178
Citation
Camillo CA, Osadnik CR, van Remoortel H, Burtin C, Janssens W, Troosters T. Effect of "add-on" interventions on exercise training in individuals with COPD: a systematic review. ERJ Open Res. 2016 Mar 29;2(1):00078-2015. doi: 10.1183/23120541.00078-2015. eCollection 2016 Jan.
Results Reference
result
Learn more about this trial
Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients
We'll reach out to this number within 24 hrs